BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32734400)

  • 21. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.
    Coleman HG; Bhat SK; Murray LJ; McManus DT; O'Neill OM; Gavin AT; Johnston BT
    Am J Gastroenterol; 2014 Apr; 109(4):527-34. PubMed ID: 24589668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett's Esophagus: An International Cohort Study.
    Kahn A; Crook J; Heckman MG; Wieczorek MA; Sami S; Snyder D; Agarwal S; Santiago J; Fernandez-Sordo JO; Tan WK; Lansing R; Wang KK; Ragunath K; DiPietro M; Wolfsen H; Ramirez F; Fleischer D; Leggett CL; Iyer PG
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2763-2771.e3. PubMed ID: 35245702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
    Ishihara R; Goda K; Oyama T
    J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic features of buried Barrett's mucosa.
    Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF
    Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
    Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
    Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
    Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
    United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy.
    Peters Y; Honing J; Kievit W; Kestens C; Pestman W; Nagtegaal ID; van der Post RS; Siersema PD
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):869-877.e5. PubMed ID: 30213587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
    Rana PS; Johnston DA
    Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
    Gatenby P; Caygill C; Wall C; Bhatacharjee S; Ramus J; Watson A; Winslet M
    World J Gastroenterol; 2014 Jul; 20(28):9611-7. PubMed ID: 25071359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
    Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
    Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).
    Rugge M; Zaninotto G; Parente P; Zanatta L; Cavallin F; Germanà B; Macrì E; Galliani E; Iuzzolino P; Ferrara F; Marin R; Nisi E; Iaderosa G; Deboni M; Bellumat A; Valiante F; Florea G; Della Libera D; Benini M; Bortesi L; Meggio A; Zorzi MG; Depretis G; Miori G; Morelli L; Cataudella G; d'Amore ES; Franceschetti I; Bozzola L; Paternello E; Antonini C; Di Mario F; Dal Bò N; Furlanetto A; Norberto L; Polese L; Iommarini S; Farinati F; Battaglia G; Diamantis G; Realdon S; Guido E; Mastropaolo G; Canova D; Guerini A; Franceschi M; Zirillo M
    Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
    Dent J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence.
    Ahmad J; Arthur K; Maxwell P; Kennedy A; Johnston BT; Murray L; McManus DT
    Dis Esophagus; 2015 Apr; 28(3):276-82. PubMed ID: 24612412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
    Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
    Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.